New Vaccine, Long-Acting Drug Trial Buoy Hopes in HIV Fight

December 1, 2017

(Reuters) – Researchers announced the launch of two big studies in Africa on Thursday to test a new HIV vaccine and a long-acting injectable drug, fuelling hopes for better ways to protect against the virus that causes AIDS.  The start of the three-year vaccine trial involving 2,600 women in southern Africa means that for the first time in more than a decade there are now two big HIV vaccine clinical trials taking place at the same time.

Recommended Reading